Financial News
Latest News about Robert Barrow
Recent news which mentions Robert Barrow
   MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
   
  August 25, 2022
  Tickers 
   MNMD
  
  
  From Benzinga
 
   MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes
   
  
  
  August 12, 2022
  From Benzinga
 
   Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International
   
  
  
  May 24, 2022
  From Benzinga
 
   MindMed Appoints Schond L. Greenway As CFO
   
  
  
  May 23, 2022
  From Benzinga
 From Benzinga
 
   MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years
   
  January 26, 2022
  Tickers 
   MNMD
  
  
  From Benzinga
 From Benzinga
 
   MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine
   
  January 04, 2022
  Tickers 
   MNMD
  
  
  From Benzinga
 
   Cannabis Movers & Shakers: MindMed & Trulieve Management Shake-Ups, Credex Corp & CapStone Bolster Leadership Teams
   
  
  
  December 29, 2021
  From Benzinga
 
   MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder
   
  December 22, 2021
  Tickers 
   MNMD
  
  
  From Benzinga
 
   MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD
   
  December 17, 2021
  Tickers 
   MNMD
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 
   Cannabis Movers & Shakers: Mind Medicine, Avant Brands, Delic, Agrify, Ascend Wellness, Pure Beauty
   
  
  
  November 11, 2021
  From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
